CGTX
NASDAQ · Pharmaceuticals
Cognition Therapeutics Inc
$0.99
+0.10 (+10.84%)
Open$0.91
Previous Close$0.89
Day High$0.99
Day Low$0.90
52W High$3.83
52W Low$0.55
Volume—
Avg Volume514.0K
Market Cap96.66M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+3,033.3% upside
Current
$0.99
$0.99
Target
$30.96
$30.96
$22.83
$30.96 avg
$36.58
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 14.30M | 12.78M | 15.45M |
| Net Income | 4.19M | 3.83M | 4.28M |
| Profit Margin | 29.3% | 30.0% | 27.7% |
| EBITDA | 6.72M | 5.55M | 6.77M |
| Free Cash Flow | 3.42M | 2.69M | 4.56M |
| Rev Growth | -4.2% | +12.1% | -7.5% |
| Debt/Equity | 0.88 | 0.74 | 0.77 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |